Infección por malaria

World Health Organization. WHO guidelines for malaria. Oct 2023 [internet publication].Texto completo

Centers for Disease Control and Prevention. Treatment of malaria: guidelines for clinicians (United States). Jun 2023 [internet publication].Texto completo

1. Snow RW, Guerra CA, Noor AM, et al. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005 Mar 10;434(7030):214-7.Texto completo  Resumen

2. Isaacson M. Airport malaria: a review. Bull World Health Organ. 1989;67(6):737-43.Texto completo  Resumen

3. Evans RJ. Nosocomial malaria. Lancet. 1997 Feb 22;349(9051):574. Resumen

4. Moro ML, Romi R, Severini C, et al. Patient-to-patient transmission of nosocomial malaria in Italy. Infect Control Hosp Epidemiol. 2002 Jun;23(6):338-41. Resumen

5. Das D, Bhattacharjee K, Ghintala S, et al. Bilateral cervical lymphadenopathy atypical presentation of malaria - a rare case report. J Clin Diagn Res. 2017 Apr;11(4):OD08-9.Texto completo  Resumen

6. Groger M, Fischer HS, Veletzky L, et al. A systematic review of the clinical presentation, treatment and relapse characteristics of human Plasmodium ovale malaria. Malar J. 2017 Mar 11;16(1):112.Texto completo  Resumen

7. World Health Organization. World malaria report 2023. Nov 2023 [internet publication].Texto completo

8. Mace KE, Lucchi NW, Tan KR. Malaria Surveillance - United States, 2018. MMWR Surveill Summ. 2022 Sep 2;71(8):1-35.Texto completo  Resumen

9. Centers for Disease Control and Prevention. Morbidity and mortality weekly report (MMWR): outbreak of locally acquired mosquito-transmitted (autochthonous) malaria - Florida and Texas, May-July 2023. Sep 2023​ [internet publication].Texto completo

10. Centers for Disease Control and Prevention. Emergency preparedness and response​: important updates on locally acquired malaria cases identified in Florida, Texas, and Maryland. Aug 2023 [internet publication].Texto completo

11. Centers for Disease Control and Prevention. Malaria: locally acquired cases of malaria in Florida, Texas, Maryland, and Arkansas​. Oct 2023 [internet publication].Texto completo

12. UK Health Security Agency. Imported malaria in the UK: statistics. Apr 2023 [internet publication].Texto completo

13. UK Health Security Agency. Malaria imported into the UK: 2021. Jun 2023 [internet publication].​Texto completo

14. World Health Organization. Global technical strategy for malaria 2016-2030, 2021 update. Jul 2021 [internet publication].Texto completo

15. World Health Organization. Global malaria programme. Countries and territories certified malaria-free by WHO. Jun 2023 [internet publication].Texto completo

16. World Health Organization. Belize certified malaria-free by WHO. Jun 2023 [internet publication].Texto completo

17. Luxemburger C, Ricci F, Nosten F, et al. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg. 1997 May-Jun;91(3):256-62. Resumen

18. Wellems TE, Miller LH. Two worlds of malaria. N Engl J Med. 2003 Oct 16;349(16):1496-8. Resumen

19. Mungai M, Tegtmeier G, Chamberland M, et al. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med. 2001 Jun 28;344(26):1973-8.Texto completo  Resumen

20. Centers for Disease Control and Prevention. Malaria outbreak: Bahia State, Brazil. Jan 2018 [internet publication].Texto completo

21. Whitty CJ, Edmonds S, Mutabingwa TK. Malaria in pregnancy. BJOG. 2005 Sep;112(9):1189-95. Resumen

22. Mendis K, Sina BJ, Marchesini P, et al. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 suppl):97-106. Resumen

23. Collins WE, Jeffery GM. Plasmodium ovale: parasite and disease. Clin Microbiol Rev. 2005 Jul;18(3):570-81.Texto completo  Resumen

24. Boudin C, Robert V, Verhave JP, et al. Plasmodium falciparum and P. malariae epidemiology in a West African village. Bull World Health Organ. 1991;69(2):199-205.Texto completo  Resumen

25. Mueller I, Zimmerman PA, Reeder JC. Plasmodium malariae and Plasmodium ovale - the "bashful" malaria parasites. Trends Parasitol. 2007 Jun;23(6):278-83. Resumen

26. Collins WE, Jeffery GM. Plasmodium malariae: parasite and disease. Clin Microbiol Rev. 2007 Oct;20(4):579-92.Texto completo  Resumen

27. Brasil P, Zalis MG, de Pina-Costa A, et al. Outbreak of human malaria caused by Plasmodium simium in the Atlantic Forest in Rio de Janeiro: a molecular epidemiological investigation. Lancet Glob Health. 2017 Oct;5(10):e1038-46.Texto completo  Resumen

28. Lalloo DG, Shingadia D, Bell DJ, et al. UK malaria treatment guidelines 2016. J Infect. 2016 Jun;72(6):635-49.Texto completo  Resumen

29. Miller LH, Baruch DI, Marsh K, et al. The pathogenic basis of malaria. Nature. 2002 Feb 7;415(6872):673-9. Resumen

30. Smith AD, Bradley DJ, Smith V, et al. Imported malaria and high risk groups: observational study using UK surveillance data 1987-2006. BMJ. 2008 Jul 3;337:a120.Texto completo  Resumen

31. Behrens RH, Carroll B, Smith V, et al. Declining incidence of malaria imported into the UK from West Africa. Malar J. 2008 Nov 10;7:235.Texto completo  Resumen

32. Behrens RH, Carroll B, Beran J, et al; TropNetEurop. The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis? Malar J. 2007 Aug 23;6:114.Texto completo  Resumen

33. Behrens RH, Bisoffi Z, Björkman A, et al; TropNetEurop. Malaria prophylaxis policy for travellers from Europe to the Indian sub-continent. Malar J. 2006 Feb 1;5:7.Texto completo  Resumen

34. Krause G, Schöneberg I, Altmann D, et al. Chemoprophylaxis and malaria death rates. Emerg Infect Dis. 2006 Mar;12(3):447-51.Texto completo  Resumen

35. Brabin BJ, Romagosa C, Abdelgalil S, et al. The sick placenta - the role of malaria. Placenta. 2004 May;25(5):359-78. Resumen

36. World Health Organization, Communicable Diseases Cluster. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000 Apr;94(suppl 1):S1-90. Resumen

37. Greenberg AE, Lobel HO. Mortality from plasmodium falciparum malaria in travelers from the United States, 1959 to 1987. Ann Intern Med. 1990 Aug 15;113(4):326-7. Resumen

38. Moore DA, Jennings RM, Doherty TF, et al. Assessing the severity of malaria. BMJ. 2003 Apr 12;326(7393):808-9.Texto completo  Resumen

39. Hammerich A, Campbell OM, Chandramohan D. Unstable malaria transmission and maternal mortality - experiences from Rwanda. Trop Med Int Health. 2002 Jul;7(7):573-6.Texto completo  Resumen

40. Moya-Alvarez V, Bodeau-Livinec F, Cot M. Iron and malaria: a dangerous liaison? Nutr Rev. 2016 Oct;74(10):612-23.Texto completo  Resumen

41. Neuberger A, Okebe J, Yahav D, et al. Oral iron supplements for children in malaria-endemic areas. Cochrane Database Syst Rev. 2016 Feb 27;(2):CD006589.Texto completo  Resumen

42. Center for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases - malaria. May 2023 [internet publication].Texto completo

43. Kolifarhood G, Raeisi A, Ranjbar M, et al. Prophylactic efficacy of primaquine for preventing Plasmodium falciparum and Plasmodium vivax parasitaemia in travelers: a meta-analysis and systematic review. Travel Med Infect Dis. 2017 May-Jun;17:5-18. Resumen

44. Radeva-Petrova D, Kayentao K, ter Kuile FO, et al. Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment. Cochrane Database Syst Rev. 2014 Oct 10;(10):CD000169.Texto completo  Resumen

45. González R, Pons-Duran C, Piqueras M, et al. Mefloquine for preventing malaria in pregnant women. Cochrane Database Syst Rev. 2018 Nov 14;(11):CD011444.Texto completo  Resumen

46. Käser AK, Arguin PM, Chiodini PL, et al. Imported malaria in pregnant women: a retrospective pooled analysis. Travel Med Infect Dis. 2015 Jul-Aug;13(4):300-10.Texto completo  Resumen

47. World Health Organization. WHO guidelines for malaria. Oct 2023 [internet publication].Texto completo

48. World Health Organization. Malaria vaccine: WHO position paper - March 2022. Wkly Epidemiol Rec. 2022;97:61-80.Texto completo

49. RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015 Jul 4;386(9988):31-45.Texto completo  Resumen

50. Björkman A, Benn CS, Aaby P, et al. RTS,S/AS01 malaria vaccine-proven safe and effective? Lancet Infect Dis. 2023 Aug;23(8):e318-22. Resumen

51. Chandramohan D, Zongo I, Sagara I, et al. Seasonal malaria vaccination with or without seasonal malaria chemoprevention. N Engl J Med. 2021 Sep 9;385(11):1005-17.Texto completo  Resumen

52. World Health Organization. WHO recommends R21/Matrix-M vaccine for malaria prevention in updated advice on immunization. Oct 2023 [internet publication].Texto completo

53. Sissoko MS, Healy SA, Katile A, et al. Safety and efficacy of PfSPZ vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial. Lancet Infect Dis. 2017 May;17(5):498-509.Texto completo  Resumen

54. Ishizuka AS, Lyke KE, DeZure A, et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat Med. 2016 Jun;22(6):614-23.Texto completo  Resumen

55. Datoo MS, Natama HM, Somé A, et al. Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. Lancet Infect Dis. 2022 Sep 7 [epub ahead of print].Texto completo  Resumen

56. Pryce J, Richardson M, Lengeler C. Insecticide-treated nets for preventing malaria. Cochrane Database Syst Rev. 2018 Nov 6;(11):CD000363.Texto completo  Resumen

57. Tiono AB, Ouédraogo A, Ouattara D, et al. Efficacy of Olyset Duo, a bednet containing pyriproxyfen and permethrin, versus a permethrin-only net against clinical malaria in an area with highly pyrethroid-resistant vectors in rural Burkina Faso: a cluster-randomised controlled trial. Lancet. 2018 Aug 18;392(10147):569-80. Resumen

58. Gleave K, Lissenden N, Chaplin M, et al. Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa. Cochrane Database Syst Rev. 2021 May 24;(5):CD012776.Texto completo  Resumen

59. Pryce J, Medley N, Choi L. Indoor residual spraying for preventing malaria in communities using insecticide-treated nets. Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD012688.Texto completo  Resumen

60. Gabaldón Figueira JC, Wagah MG, Adipo LB, et al. Topical repellents for malaria prevention. Cochrane Database Syst Rev. 2023 Aug 21;8(8):CD015422.Texto completo  Resumen

61. Fox T, Furnival-Adams J, Chaplin M, et al. House modifications for preventing malaria. Cochrane Database Syst Rev. 2022 Oct 6;10(10):CD013398.Texto completo  Resumen

62. Walshe DP, Garner P, Adeel AA, et al. Larvivorous fish for preventing malaria transmission. Cochrane Database Syst Rev. 2017 Dec 11;(12):CD008090.Texto completo  Resumen

63. Pryce J, Choi L, Richardson M, et al. Insecticide space spraying for preventing malaria transmission. Cochrane Database Syst Rev. 2018 Nov 2;(11):CD012689.Texto completo  Resumen

64. Choi L, Majambere S, Wilson AL. Larviciding to prevent malaria transmission. Cochrane Database Syst Rev. 2019 Aug 14;(8):CD012736.Texto completo  Resumen

65. Esu EB, Oringanje C, Meremikwu MM. Intermittent preventive treatment for malaria in infants. Cochrane Database Syst Rev. 2021 Jul 17;(7):CD011525.Texto completo  Resumen

66. Shah MP, Hwang J, Choi L, et al. Mass drug administration for malaria. Cochrane Database Syst Rev. 2021 Sep 29;(9):CD008846.Texto completo  Resumen

67. Payne D. Use and limitations of light microscopy for diagnosing malaria at the primary health care level. Bull World Health Organ. 1988;66(5):621-6.Texto completo  Resumen

68. Pattanasin S, Proux S, Chompasuk D, et al. Evaluation of a new Plasmodium lactate dehydrogenase assay (OptiMAL-IT) for the detection of malaria. Trans R Soc Trop Med Hyg. 2003 Nov-Dec;97(6):672-4. Resumen

69. Ashley E, Touabi M, Ahrer M, et al. Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria. Malar J. 2009 Oct 27;8:241.Texto completo  Resumen

70. Yerlikaya S, Campillo A, Gonzalez IJ. A Systematic Review: Performance of rapid diagnostic tests for the detection of Plasmodium knowlesi, Plasmodium malariae, and Plasmodium ovale Monoinfections in human blood. J Infect Dis. 2018 Jun 20;218(2):265-76.Texto completo  Resumen

71. Stauffer WM, Cartwright CP, Olson DA, et al. Diagnostic performance of rapid diagnostic tests versus blood smears for malaria in US clinical practice. Clin Infect Dis. 2009 Sep 15;49(6):908-13.Texto completo  Resumen

72. Nicastri E, Bevilacqua N, Sañé Schepisi M, et al. Accuracy of malaria diagnosis by microscopy, rapid diagnostic test, and PCR methods and evidence of antimalarial overprescription in non-severe febrile patients in two Tanzanian hospitals. Am J Trop Med Hyg. 2009 May;80(5):712-7.Texto completo  Resumen

73. Odaga J, Sinclair D, Lokong JA, et al. Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings. Cochrane Database Syst Rev. 2014 Apr 17;(4):CD008998.Texto completo  Resumen

74. Allen EN, Wiyeh AB, McCaul M. Adding rapid diagnostic tests to community-based programmes for treating malaria. Cochrane Database Syst Rev. 2022 Sep 8;(9):CD009527.Texto completo  Resumen

75. World Health Organization. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2/3 gene deletions. Jul 2019 [internet publication].Texto completo

76. Gillet P, Scheirlinck A, Stokx J, et al. Prozone in malaria rapid diagnostics tests: how many cases are missed? Malar J. 2011 Jun 15;10:166.Texto completo  Resumen

77. Li B, Sun Z, Li X, et al. Performance of pfHRP2 versus pLDH antigen rapid diagnostic tests for the detection of Plasmodium falciparum: a systematic review and meta-analysis. Arch Med Sci. 2017 Apr 1;13(3):541-9.Texto completo  Resumen

78. Das S, Peck RB, Barney R, et al. Performance of an ultra-sensitive Plasmodium falciparum HRP2-based rapid diagnostic test with recombinant HRP2, culture parasites, and archived whole blood samples. Malar J. 2018 Mar 17;17(1):118.Texto completo  Resumen

79. Hanscheid T. Diagnosis of malaria: a review of alternatives to conventional microscopy. Clin Lab Haematol. 1999 Aug;21(4):235-45. Resumen

80. Oliveira DA, Holloway BP, Durigon EL, et al. Polymerase chain reaction and a liquid-phase, nonisotopic hybridization for species-specific and sensitive detection of malaria infection. Am J Trop Med Hyg. 1995 Feb;52(2):139-44. Resumen

81. Heinemann M, Phillips RO, Vinnemeier CD, et al. High prevalence of asymptomatic malaria infections in adults, Ashanti Region, Ghana, 2018. Malar J. 2020 Oct 12;19(1):366.Texto completo  Resumen

82. Rogerson SJ, Hviid L, Duffy PE,et al. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis. 2007 Feb;7(2):105-17. Resumen

83. Polley SD, González IJ, Mohamed D, et al. Clinical evaluation of a loop-mediated amplification kit for diagnosis of imported malaria. J Infect Dis. 2013 Aug 15;208(4):637-44.Texto completo  Resumen

84. Hopkins H, González IJ, Polley SD, et al. Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis. 2013 Aug 15;208(4):645-52.Texto completo  Resumen

85. Lavi R, Yarnitsky D, Rowe JM, et al. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology. 2006 Oct 24;67(8):1492-4. Resumen

86. Arendt K, Demaerschalk BM, Wingerchuk DM, Camann W. Atraumatic lumbar puncture needles: after all these years, are we still missing the point? Neurologist. 2009 Jan;15(1):17-20. Resumen

87. Nath S, Koziarz A, Badhiwala JH, et al. Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis. Lancet. 2018 Mar 24;391(10126):1197-204. Resumen

88. Rochwerg B, Almenawer SA, Siemieniuk RAC, et al. Atraumatic (pencil-point) versus conventional needles for lumbar puncture: a clinical practice guideline. BMJ. 2018 May 22;361:k1920.Texto completo  Resumen

89. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006 Nov;82(973):713-6.Texto completo  Resumen

90. Arevalo-Rodriguez I, Ciapponi A, Roqué i Figuls M, et al. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2016 Mar 7;(3):CD009199.Texto completo  Resumen

91. Hanson J, Hossain A, Charunwatthana P, et al. Hyponatremia in severe malaria: evidence for an appropriate anti-diuretic hormone response to hypovolemia. Am J Trop Med Hyg. 2009 Jan;80(1):141-5.Texto completo  Resumen

92. Auwaerter PG. Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control? Expert Rev Anti Infect Ther. 2006 Dec;4(6):1039-49. Resumen

93. Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 11: newly arrived immigrants, refugees & other migrants. May 2023 [internet publication].​Texto completo

94. Centers for Disease Control and Prevention. Treatment of malaria: guidelines for clinicians (United States). Jun 2023 [internet publication].Texto completo

95. Adjuik M, Babiker A, Garner P, et al. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004 Jan 3;363(9402):9-17. Resumen

96. World Health Organization. Malaria: withdrawal of oral artemisinin-based monotherapies. Oct 2017 [internet publication].Texto completo

97. Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet. 1996 Jun 15;347(9016):1654-8. Resumen

98. Sinclair D, Zani B, Donegan S, et al. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007483.Texto completo  Resumen

99. Hatz C, Soto J, Nothdurft HD, et al. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study. Am J Trop Med Hyg. 2008 Feb;78(2):241-7.Texto completo  Resumen

100. Zoller T, Junghanss T, Kapaun A, et al. Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis. 2011 May;17(5):771-7.Texto completo  Resumen

101. Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG, et al. Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Malar J. 2012 Mar 31;11:102.Texto completo  Resumen

102. Rolling T, Schmiedel S, Wichmann D, et al. Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia. Malar J. 2012 May 17;11:169.Texto completo  Resumen

103. Askling HH, Bruneel F, Burchard G, et al. Management of imported malaria in Europe. Malar J. 2012 Sep 17;11:328.Texto completo  Resumen

104. D'Acremont V, Landry P, Mueller I, et al. Clinical and laboratory predictors of imported malaria in an outpatient setting: an aid to medical decision making in returning travelers with fever. Am J Trop Med Hyg. 2002 May;66(5):481-6.Texto completo  Resumen

105. Melzer M, Lacey S, Rait G. The case for outpatient treatment of Plasmodium falciparum malaria in a selected UK immigrant population. J Infect. 2009 Oct;59(4):259-63. Resumen

106. Toovey S. Effectiveness of co-artemether in an unsupervised outpatient setting for the treatment of falciparum malaria. Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):29-31. Resumen

107. Briand V, Bouchaud O, Tourret J, et al. Hospitalization criteria in imported falciparum malaria. J Travel Med. 2007 Sep-Oct;14(5):306-11.Texto completo  Resumen

108. US Food and Drug Administration. Mefloquine hydrochloride: drug safety communication - FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of serious psychiatric and nerve side effects. Jul 2013 [internet publication].Texto completo

109. Zani B, Gathu M, Donegan S, et al. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev. 2014 Jan 20;(1):CD010927.Texto completo  Resumen

110. Sondén K, Wyss K, Jovel I, et al. High rate of treatment failures in nonimmune travelers treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Sweden: retrospective comparative analysis of effectiveness and case series. Clin Infect Dis. 2017 Jan 15;64(2):199-206.Texto completo  Resumen

111. Pryce J, Taylor M, Fox T, et al. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev. 2022 Jun 21;(6):CD006404.Texto completo  Resumen

112. Amaratunga C, Lim P, Suon S, et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016 Mar;16(3):357-65.Texto completo  Resumen

113. Chan XHS, Win YN, Mawer LJ, et al. Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis. Lancet Infect Dis. 2018 Aug;18(8):913-23.Texto completo  Resumen

114. Blanshard A, Hine P. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev. 2021 Jan 15;(1):CD004529.Texto completo  Resumen

115. Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014 Nov 3;13:418.Texto completo  Resumen

116. Graves PM, Choi L, Gelband H, et al. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission. Cochrane Database Syst Rev. 2018 Feb 2;(2):CD008152.Texto completo  Resumen

117. Centers for Disease Control and Prevention. Availability of intravenous artesunate for treatment of severe malaria in the United States. Mar 2019 [internet publication].Texto completo

118. World Health Organization. The use of rectal artesunate as a pre-referral treatment for severe P. falciparum malaria. Jul 2023 [internet publication].Texto completo

119. Esu EB, Effa EE, Opie ON, et al. Artemether for severe malaria. Cochrane Database Syst Rev. 2019 Jun 18;(6):CD010678.Texto completo  Resumen

120. Cox-Singh J, Davis TM, Lee KS, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis. 2008 Jan 15;46(2):165-71.Texto completo  Resumen

121. Sumawinata IW, Bernadeta, Leksana B, et al. Very high risk of therapeutic failure with chloroquine for uncomplicated plasmodium falciparum and P vivax malaria in Indonesian Papua. Am J Trop Med Hyg. 2003 Apr;68(4):416-20.Texto completo  Resumen

122. John GK, Douglas NM, von Seidlein L, et al. Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J. 2012 Aug 17;11:280.Texto completo  Resumen

123. Milligan R, Daher A, Villanueva G, et al. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax. Cochrane Database Syst Rev. 2020 Aug 19;(8):CD012656.Texto completo  Resumen

124. Taylor WRJ, Thriemer K, von Seidlein L, et al. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. Lancet. 2019 Sep 14;394(10202):929-38.Texto completo  Resumen

125. World Health Organization. Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale. Oct 2016 [internet publication].Texto completo

126. Thriemer K, Degaga TS, Christian M, et al. Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial. Lancet. 2023 Dec 02;402(10417):2101-10.Texto completo

127. Hill DR, Baird JK, Parise ME, et al. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg. 2006 Sep;75(3):402-15.Texto completo  Resumen

128. Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007 Feb;7(2):93-104. Resumen

129. Moore KA, Simpson JA, Scoullar MJL, et al. Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis. Lancet Glob Health. 2017 Nov;5(11):e1101-12.Texto completo  Resumen

130. Cates JE, Unger HW, Briand V, et al. Malaria, malnutrition, and birthweight: a meta-analysis using individual participant data. PLoS Med. 2017 Aug 8;14(8):e1002373.Texto completo  Resumen

131. Newman RD, Parise ME, Slutsker L, et al. Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Trop Med Int Health. 2003 Jun;8(6):488-506.Texto completo  Resumen

132. Kovacs SD, van Eijk AM, Sevene E, et al. The safety of artemisinin derivatives for the treatment of malaria in the 2nd or 3rd trimester of pregnancy: a systematic review and meta-analysis. PLoS One. 2016 Nov 8;11(11):e0164963.Texto completo  Resumen

133. Saito M, Mansoor R, Kennon K, et al. Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis. Lancet Infect Dis. 2020 Aug;20(8):943-52.Texto completo  Resumen

134. Dellicour S, Sevene E, McGready R, et al. First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies. PLoS Med. 2017 May;14(5):e1002290.Texto completo  Resumen

135. Osarfo J, Tagbor H, Cairns M, et al. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine for treatment of malaria infection in pregnancy in Ghana: an open-label, randomised, non-inferiority trial. Trop Med Int Health. 2017 Aug;22(8):1043-52.Texto completo  Resumen

136. Pekyi D, Ampromfi AA, Tinto H, et al; PREGACT Study Group. Four artemisinin-based treatments in African pregnant women with malaria. N Engl J Med. 2016 Mar 10;374(10):913-27.Texto completo  Resumen

137. Kakuru A, Jagannathan P, Muhindo MK, et al. Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy. N Engl J Med. 2016 Mar 10;374(10):928-39.Texto completo  Resumen

138. Desai M, Gutman J, L'Ianziva A, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet. 2015 Dec 19;386(10012):2507-19.Texto completo  Resumen

139. Burger RJ, van Eijk AM, Bussink M, et al. Artemisinin-based combination therapy versus quinine or other combinations for treatment of uncomplicated Plasmodium falciparum malaria in the second and third trimester of pregnancy: a systematic review and meta-analysis. Open Forum Infect Dis. 2015 Nov 12;3(1):ofv170.Texto completo  Resumen

140. Mavoko HM, Nabasumba C, da Luz RI, et al. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial. Lancet Glob Health. 2017 Jan;5(1):e60-8.Texto completo  Resumen

141. World Health Organization. Status report on artemisinin resistance and artemisinin-based combination therapy efficacy. Dec 2019 [internet publication].Texto completo

142. Maitland K, Kiguli S, Opoka RO, et al; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011 Jun 30;364(26):2483-95.Texto completo  Resumen

143. Commons RJ, Simpson JA, Thriemer K, et al. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis. Lancet Infect Dis. 2018 Sep;18(9):1025-34.Texto completo  Resumen

144. Rodrigo C, Rajapakse S, Fernando D. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev. 2020 Sep 6;(9):CD010458.Texto completo  Resumen

145. Sutanto I, Soebandrio A, Ekawati LL, et al. Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study. Lancet Infect Dis. 23 May 2023 [Epub ahead of print].Texto completo  Resumen

146. Haston JC, Hwang J, Tan KR. Guidance for using tafenoquine for prevention and antirelapse therapy for malaria - United States, 2019. MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1062-8.Texto completo  Resumen

147. de Souza DK, Thomas R, Bradley J, et al. Ivermectin treatment in humans for reducing malaria transmission. Cochrane Database Syst Rev. 2021 Jun 29;(6):CD013117.Texto completo  Resumen

148. Plewes K, Kingston HWF, Ghose A, et al. Acetaminophen as a renoprotective adjunctive treatment in patients with severe and moderately severe falciparum malaria: a randomized, controlled, open-label trial. Clin Infect Dis. 2018 Sep 14;67(7):991-9.Texto completo  Resumen

149. Cooper DJ, Grigg MJ, Plewes K, et al. The effect of regularly dosed acetaminophen versus no acetaminophen on renal function in Plasmodium knowlesi malaria (PACKNOW): a randomised controlled trial. Clin Infect Dis. 2022 Feb 18:ciac152.Texto completo

150. Wu RL, Idris AH, Berkowitz NM, et al. Low-dose subcutaneous or intravenous monoclonal antibody to prevent malaria. N Engl J Med. 2022 Aug 4;387(5):397-407.Texto completo  Resumen

151. Winters RA, Murray HW. Malaria - the mime revisited: fifteen more years of experience at a New York City teaching hospital. Am J Med. 1992 Sep;93(3):243-6. Resumen

152. Behrens RH, Curtis CF. Malaria in travellers: epidemiology and prevention. Br Med Bull. 1993 Apr;49(2):363-81. Resumen

153. White NJ. Not much progress in the treatment of cerebral malaria. Lancet. 1998 Aug 22;352(9128):594-5. Resumen

154. Bruneel F, Tubach F, Corne P, et al. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS One. 2010 Oct 8;5(10):e13236.Texto completo  Resumen

155. Checkley AM, Smith A, Smith V, et al. Risk factors for mortality from imported falciparum malaria in the United Kingdom over 20 years: an observational study. BMJ. 2012 Mar 27;344:e2116. [Erratum in: BMJ. 2012 April 16;344:e2709.]Texto completo  Resumen

156. Sypniewska P, Duda JF, Locatelli I, et al. Clinical and laboratory predictors of death in African children with features of severe malaria: a systematic review and meta-analysis. BMC Med. 2017 Aug 3;15(1):147.Texto completo  Resumen

157. English M, Waruiru C, Amukoye E, et al. Deep breathing in children with severe malaria: indicador of metabolic acidosis and poor outcome. Am J Trop Med Hyg. 1996 Nov;55(5):521-4. Resumen

158. Lon C, Spring M, Sok S, et al. Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine. Malar J. 2014 Mar 14;13:96.Texto completo  Resumen

159. Yadava SK, Laleker A, Fazili T. Post-malaria neurological syndrome: a rare neurological complication of malaria. Infection. 2019 Apr;47(2):183-93.Texto completo  Resumen

160. Tamzali Y, Demeret S, Haddad E, et al. Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework. Malar J. 2018 Oct 26;17(1):387.Texto completo  Resumen

161. Val F, Machado K, Barbosa L, et al. Respiratory complications of Plasmodium vivax malaria: systematic review and meta-analysis. Am J Trop Med Hyg. 2017 Sep;97(3):733-43.Texto completo  Resumen